Genomic Data Sharing for Novel Mendelian Disease Gene Discovery: The Matchmaker Exchange

Literature Cited

1. 1. 

   ACMG Board Dir 2017. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics. Genet. Med. 19:721–22
   [Google Scholar]
2. 2. 

   Adachi T, Kawamura K, Furusawa Y, Nishizaki Y, Imanishi N et al. 2017. Japan's Initiative on Rare and Undiagnosed Diseases (IRUD): towards an end to the diagnostic odyssey. Eur. J. Hum. Genet. 25:1025–28
   [Google Scholar]
3. 3. 

   Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A 2015. OMIM.org: Online Mendelian Inheritance in Man (OMIM^®), an online catalog of human genes and genetic disorders. Nucleic Acids Res 43:D789–98
   [Google Scholar]
4. 4. 

   Arachchi H, Wojcik MH, Weisburd B, Jacobsen JOB, Valkanas E et al. 2018. matchbox: an open-source tool for patient matching via the Matchmaker Exchange. Hum. Mutat. 39:1827–34
   [Google Scholar]
5. 5. 

   Assoum M, Philippe C, Isidor B, Perrin L, Makrythanasis P et al. 2016. Autosomal-recessive mutations in AP3B2, adaptor-related protein complex 3 beta 2 subunit, cause an early-onset epileptic encephalopathy with optic atrophy. Am. J. Hum. Genet. 99:1368–76
   [Google Scholar]
6. 6. 

   Austin CP, Cutillo CM, Lau LPL, Jonker AH, Rath A et al. 2018. Future of rare diseases research 2017–2027: an IRDiRC perspective. Clin. Transl. Sci. 11:21–27
   [Google Scholar]
7. 7. 

   Bamshad MJ, Nickerson DA, Chong JX 2019. Mendelian gene discovery: fast and furious with no end in sight. Am. J. Hum. Genet. 105:448–55
   [Google Scholar]
8. 8. 

   Basilicata MF, Bruel A-L, Semplicio G, Valsecchi CIK, Aktaş T et al. 2018. De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation. Nat. Genet. 50:1442–51
   [Google Scholar]
9. 9. 

   Baynam G, Walters M, Claes P, Kung S, LeSouef P et al. 2015. Phenotyping: targeting genotype's rich cousin for diagnosis. J. Paediatr. Child Health 51:381–86
   [Google Scholar]
10. 10. 

    Boerkoel C, du Souich C 2017. UNC80 deficiency. GeneReviews MP Adam, HH Ardinger, RA Pagon, SE Wallace, LJH Bean, et al Seattle: Univ. Wash https://www.ncbi.nlm.nih.gov/books/NBK453434
    [Google Scholar]
11. 11. 

    Boycott KM, Campeau PM, Howley HE, Pavlidis P, Rogic S et al. 2020. The Canadian Rare Diseases Models and Mechanisms (RDMM) Network: connecting understudied genes to model organisms. Am. J. Hum. Genet. 106:143–52
    [Google Scholar]
12. 12. 

    Boycott KM, Rath A, Chong JX, Hartley T, Alkuraya FS et al. 2017. International cooperation to enable the diagnosis of all rare genetic diseases. Am. J. Hum. Genet. 100:695–705
    [Google Scholar]
13. 13. 

    Bruel A-L, Bigoni S, Kennedy J, Whiteford M, Buxton C et al. 2017. Expanding the clinical spectrum of recessive truncating mutations of KLHL7 to a Bohring-Opitz-like phenotype. J. Med. Genet. 54:830–35
    [Google Scholar]
14. 14. 

    Buske OJ, Girdea M, Dumitriu S, Gallinger B, Hartley T et al. 2015. PhenomeCentral: a portal for phenotypic and genotypic matchmaking of patients with rare genetic diseases. Hum. Mutat. 36:931–40
    [Google Scholar]
15. 15. 

    Buske OJ, Schiettecatte F, Hutton B, Dumitriu S, Misyura A et al. 2015. The Matchmaker Exchange API: automating patient matching through the exchange of structured phenotypic and genotypic profiles. Hum. Mutat. 36:922–27Description of the Matchmaker Exchange API for exchanging phenotype and genotype profiles.
    [Google Scholar]
16. 16. 

    Carapito R, Ivanova EL, Morlon A, Meng L, Molitor A et al. 2019. ZMIZ1 variants cause a syndromic neurodevelopmental disorder. Am. J. Hum. Genet. 104:319–30
    [Google Scholar]
17. 17. 

    Chong JX, Yu J-H, Lorentzen P, Park KM, Jamal SM et al. 2016. Gene discovery for Mendelian conditions via social networking: de novo variants in KDM1A cause developmental delay and distinctive facial features. Genet. Med. 18:788–95
    [Google Scholar]
18. 18. 

    Clark MM, Stark Z, Farnaes L, Tan TY, White SM et al. 2018. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. npj Genom. Med. 3:16
    [Google Scholar]
19. 19. 

    Dawkins HJS, Draghia-Akli R, Lasko P, Lau LPL, Jonker AH et al. 2018. Progress in rare diseases research 2010–2016: an IRDiRC perspective. Clin. Transl. Sci. 11:11–20
    [Google Scholar]
20. 20. 

    Dobyns WB, Aldinger KA, Ishak GE, Mirzaa GM, Timms AE et al. 2018. MACF1 mutations encoding highly conserved zinc-binding residues of the GAR domain cause defects in neuronal migration and axon guidance. Am. J. Hum. Genet. 103:1009–21
    [Google Scholar]
21. 21. 

    Dyke SOM, Knoppers BM, Hamosh A, Firth HV, Hurles M et al. 2017. “Matching” consent to purpose: the example of the Matchmaker Exchange. Hum. Mutat. 38:1281–85A full explanation of the Matchmaker Exchange tiered consent policy.
    [Google Scholar]
22. 22. 

    Eilbeck K, Lewis SE, Mungall CJ, Yandell M, Stein L et al. 2005. The Sequence Ontology: a tool for the unification of genome annotations. Genome Biol 6:R44
    [Google Scholar]
23. 23. 

    Farwell Hagman KD, Shinde DN, Mroske C, Smith E, Radtke K et al. 2017. Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. Genet. Med. 19:224–35
    [Google Scholar]
24. 24. 

    Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M et al. 2009. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am. J. Hum. Genet. 84:524–33
    [Google Scholar]
25. 25. 

    Fischer-Zirnsak B, Segebrecht L, Schubach M, Charles P, Alderman E et al. 2019. Haploinsufficiency of the notch ligand DLL1 causes variable neurodevelopmental disorders. Am. J. Hum. Genet. 105:631–39
    [Google Scholar]
26. 26. 

    Friedman J, Smith DE, Issa MY, Stanley V, Wang R et al. 2019. Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy. Nat. Commun. 10:707
    [Google Scholar]
27. 27. 

    Frints SGM, Hennig F, Colombo R, Jacquemont S, Terhal P et al. 2019. Deleterious de novo variants of X-linked ZC4H2 in females cause a variable phenotype with neurogenic arthrogryposis multiplex congenita. Hum. Mutat. 40:2270–85
    [Google Scholar]
28. 28. 

    Fujiwara T, Yamamoto Y, Kim J-D, Buske O, Takagi T 2018. PubCaseFinder: a case-report-based, phenotype-driven differential-diagnosis system for rare diseases. Am. J. Hum. Genet. 103:389–99
    [Google Scholar]
29. 29. 

    GeneMatcher 2019. Publications. GeneMatcher http://genematcher.org/publications
    [Google Scholar]
30. 30. 

    Girdea M, Dumitriu S, Fiume M, Bowdin S, Boycott KM et al. 2013. PhenoTips: patient phenotyping software for clinical and research use. Hum. Mutat. 34:1057–65
    [Google Scholar]
31. 31. 

    Glob. Alliance Genom. Health 2016. A federated ecosystem for sharing genomic, clinical data. Science 352:1278–80
    [Google Scholar]
32. 32. 

    Glob. Alliance Genom. Health 2020. Documentation for the MatchmakerExchange APIs. GitHub https://github.com/ga4gh/mme-apis
    [Google Scholar]
33. 33. 

    Glob. Alliance Genom. Health. 2020. Metrics API. GitHub https://github.com/ga4gh/mme-apis/blob/master/metrics-api.md
    [Google Scholar]
34. 34. 

    Guissart C, Latypova X, Rollier P, Khan TN, Stamberger H et al. 2018. Dual molecular effects of dominant RORA mutations cause two variants of syndromic intellectual disability with either autism or cerebellar ataxia. Am. J. Hum. Genet. 102:744–59
    [Google Scholar]
35. 35. 

    Hung CY, Volkmar B, Baker JD, Bauer JW, Gussoni E et al. 2017. A defect in the inner kinetochore protein CENPT causes a new syndrome of severe growth failure. PLOS ONE 12:e0189324
    [Google Scholar]
36. 36. 

    Ito Y, Carss KJ, Duarte ST, Hartley T, Keren B et al. 2018. De novo truncating mutations in WASF1 cause intellectual disability with seizures. Am. J. Hum. Genet. 103:144–53
    [Google Scholar]
37. 37. 

    Johnstone DL, Nguyen T-T-M, Murakami Y, Kernohan KD, Tétreault M et al. 2017. Compound heterozygous mutations in the gene PIGP are associated with early infantile epileptic encephalopathy. Hum. Mol. Genet. 26:1706–15
    [Google Scholar]
38. 38. 

    Kernohan KD, Dyment DA, Pupavac M, Cramer Z, McBride A et al. 2017. Matchmaking facilitates the diagnosis of an autosomal-recessive mitochondrial disease caused by biallelic mutation of the tRNA isopentenyltransferase (TRIT1) gene. Hum. Mutat. 38:511–16
    [Google Scholar]
39. 39. 

    Knaus A, Kortüm F, Kleefstra T, Stray-Pedersen A, Đukić D et al. 2019. Mutations in PIGU impair the function of the GPI transamidase complex, causing severe intellectual disability, epilepsy, and brain anomalies. Am. J. Hum. Genet. 105:395–402
    [Google Scholar]
40. 40. 

    Köhler S, Carmody L, Vasilevsky N, Jacobsen JOB, Danis D et al. 2019. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res 47:D1018–27
    [Google Scholar]
41. 41. 

    Lambertson KF, Damiani SA, Might M, Shelton R, Terry SF 2015. Participant-driven matchmaking in the genomic era. Hum. Mutat. 36:965–73
    [Google Scholar]
42. 42. 

    Lee S, Chen DY, Zaki MS, Maroofian R, Houlden H et al. 2019. Bi-allelic loss of human APC2, encoding adenomatous polyposis coli protein 2, leads to lissencephaly, subcortical heterotopia, and global developmental delay. Am. J. Hum. Genet. 105:844–53
    [Google Scholar]
43. 43. 

    Liang L, Li X, Moutton S, Schrier Vergano SA, Cogné B et al. 2019. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes. Hum. Mol. Genet. 28:2937–51
    [Google Scholar]
44. 44. 

    Lochmüller H, Le Cam Y, Jonker AH, Lau LPL, Baynam G et al. 2017. ‘IRDiRC Recognized Resources’: a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases. Eur. J. Hum. Genet. 25:162–65
    [Google Scholar]
45. 45. 

    Martinelli S, Krumbach OHF, Pantaleoni F, Coppola S, Amin E et al. 2018. Functional dysregulation of CDC42 causes diverse developmental phenotypes. Am. J. Hum. Genet. 102:309–20
    [Google Scholar]
46. 46. 

    Matchmaker Exch 2017. Matchmaker Exchange end user agreement. Matchmaker Exchange https://www.matchmakerexchange.org/assets/files/MatchmakerExchangeEndUserAgreement.pdf
    [Google Scholar]
47. 47. 

    Matchmaker Exch 2019. Matchmaker Exchange service requirements. Matchmaker Exchange https://www.matchmakerexchange.org/assets/files/Matchmaker%20Exchange%20Service%20Requirements_March2019.pdf
    [Google Scholar]
48. 48. 

    Matchmaker Exch 2020. Matchmaker Exchange welcomes the chance to work with you. Matchmaker Exchange https://www.matchmakerexchange.org/i_am_a_clinician_laboratory.html
    [Google Scholar]
49. 49. 

    Might M, Wilsey M. 2014. The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated. Genet. Med. 16:736–37
    [Google Scholar]
50. 50. 

    Mirzaa GM, Chong JX, Piton A, Popp B, Foss K et al. 2019. De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder. Genet. Med. 22:538–46
    [Google Scholar]
51. 51. 

    Mungall CJ, Washington NL, Nguyen-Xuan J, Condit C, Smedley D et al. 2015. Use of model organism and disease databases to support matchmaking for human disease gene discovery. Hum. Mutat. 36:979–84
    [Google Scholar]
52. 52. 

    Natl. Inst. Health 2014. NIH Genomic Data Sharing Policy Not. NOT-OD-14-124, Natl. Inst. Health Bethesda, MD: https://grants.nih.gov/grants/guide/notice-files/not-od-14-124.html
53. 53. 

    Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK et al. 2010. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 42:30–35
    [Google Scholar]
54. 54. 

    O'Donnell-Luria AH, Pais LS, Faundes V, Wood JC, Sveden A et al. 2019. Heterozygous variants in KMT2E cause a spectrum of neurodevelopmental disorders and epilepsy. Am. J. Hum. Genet. 104:1210–22
    [Google Scholar]
55. 55. 

    Oud MM, Tuijnenburg P, Hempel M, van Vlies N, Ren Z et al. 2017. Mutations in EXTL3 cause neuro-immuno-skeletal dysplasia syndrome. Am. J. Hum. Genet. 100:281–96
    [Google Scholar]
56. 56. 

    Palmer EE, Kumar R, Gordon CT, Shaw M, Hubert L et al. 2017. A recurrent de novo nonsense variant in ZSWIM6 results in severe intellectual disability without frontonasal or limb malformations. Am. J. Hum. Genet. 101:995–1005
    [Google Scholar]
57. 57. 

    Patak J, Gilfert J, Byler M, Neerukonda V, Thiffault I et al. 2019. MAGEL2-related disorders: a study and case series. Clin. Genet. 96:493–505
    [Google Scholar]
58. 58. 

    Philippakis AA, Azzariti DR, Beltran S, Brookes AJ, Brownstein CA et al. 2015. The Matchmaker Exchange: a platform for rare disease gene discovery. Hum. Mutat. 36:915–21The primary reference providing a comprehensive overview of the Matchmaker Exchange.
    [Google Scholar]
59. 59. 

    Rare Dis. Clin. Res. Netw 2011. The Office of Rare Diseases Research (ORDR). Rare Diseases Clinical Research Network https://www.rarediseasesnetwork.org/spotlight/spring2011/ORDR
    [Google Scholar]
60. 60. 

    Saunders G, Baudis M, Becker R, Beltran S, Béroud C et al. 2019. Leveraging European infrastructures to access 1 million human genomes by 2022. Nat. Rev. Genet. 20:693–701
    [Google Scholar]
61. 61. 

    Savatt JM, Azzariti DR, Faucett WA, Harrison S, Hart J et al. 2018. ClinGen's GenomeConnect registry enables patient-centered data sharing. Hum. Mutat. 39:1668–76
    [Google Scholar]
62. 62. 

    SciLifeLab Clin. Genom 2020. PatientMatcher. GitHub https://github.com/Clinical-Genomics/patientMatcher
    [Google Scholar]
63. 63. 

    Shefchek KA, Harris NL, Gargano M, Matentzoglu N, Unni D et al. 2019. The Monarch Initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across species. Nucleic Acids Res 48:D704–15
    [Google Scholar]
64. 64. 

    Skraban CM, Wells CF, Markose P, Cho MT, Nesbitt AI et al. 2017. WDR26 haploinsufficiency causes a recognizable syndrome of intellectual disability, seizures, abnormal gait, and distinctive facial features. Am. J. Hum. Genet. 101:139–48
    [Google Scholar]
65. 65. 

    Smedley D, Jacobsen JOB, Jäger M, Köhler S, Holtgrewe M et al. 2015. Next-generation diagnostics and disease-gene discovery with the Exomiser. Nat. Protoc. 10:2004–15
    [Google Scholar]
66. 66. 

    Snijders Blok L, Kleefstra T, Venselaar H, Maas S, Kroes HY et al. 2019. De novo variants disturbing the transactivation capacity of POU3F3 cause a characteristic neurodevelopmental disorder. Am. J. Hum. Genet. 105:403–12
    [Google Scholar]
67. 67. 

    Sobreira NLM, Arachchi H, Buske OJ, Chong JX, Hutton B et al. 2017. Matchmaker Exchange. Curr. Protoc. Hum. Genet. 95:931.1–15A practical guide to get started initiating a query across the Matchmaker Exchange.
    [Google Scholar]
68. 68. 

    Sobreira NLM, Schiettecatte F, Boehm C, Valle D, Hamosh A 2015. New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene. Hum. Mutat. 36:425–31
    [Google Scholar]
69. 69. 

    Sobreira NLM, Schiettecatte F, Valle D, Hamosh A 2015. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum. Mutat. 36:928–30
    [Google Scholar]
70. 70. 

    Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M et al. 2017. Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource. Am. J. Hum. Genet. 100:895–906
    [Google Scholar]
71. 71. 

    Stray-Pedersen A, Cobben J-M, Prescott TE, Lee S, Cang C et al. 2016. Biallelic mutations in UNC80 cause persistent hypotonia, encephalopathy, growth retardation, and severe intellectual disability. Am. J. Hum. Genet. 98:202–9
    [Google Scholar]
72. 72. 

    Takenouchi T, Kosaki R, Niizuma T, Hata K, Kosaki K 2015. Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: yet another locus for thrombocytopenia and developmental delay. Am. J. Med. Genet. A 167:2822–25
    [Google Scholar]
73. 73. 

    Takenouchi T, Yamaguchi Y, Tanikawa A, Kosaki R, Okano H, Kosaki K 2015. Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation. J. Pediatr. 166:483–86
    [Google Scholar]
74. 74. 

    Tanaka AJ, Cho MT, Millan F, Juusola J, Retterer K et al. 2015. Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss. Am. J. Hum. Genet. 97:457–64
    [Google Scholar]
75. 75. 

    Thompson R, Johnston L, Taruscio D, Monaco L, Béroud C et al. 2014. RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. J. Gen. Intern. Med. 29:Suppl. 3S780–87
    [Google Scholar]
76. 76. 

    Wang J, Al-Ouran R, Hu Y, Kim S-Y, Wan Y-W et al. 2017. MARRVEL: integration of human and model organism genetic resources to facilitate functional annotation of the human genome. Am. J. Hum. Genet. 100:843–53
    [Google Scholar]
77. 77. 

    Wangler MF, Yamamoto S, Chao H-T, Posey JE, Westerfield M et al. 2017. Model organisms facilitate rare disease diagnosis and therapeutic research. Genetics 207:9–27
    [Google Scholar]
78. 78. 

    Wright CF, Ware JS, Lucassen AM, Hall A, Middleton A et al. 2019. Genomic variant sharing: a position statement. Wellcome Open Res 4:22
    [Google Scholar]
79. 79. 

    Yates TM, Vasudevan PC, Chandler KE, Donnelly DE, Stark Z et al. 2017. De novo mutations in HNRNPU result in a neurodevelopmental syndrome. Am. J. Med. Genet. A 173:3003–12
    [Google Scholar]